|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.1 NOK | -2.88% |
|
-3.81% | -3.81% |
| 03-01 | Arctic Bioscience AS Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03-01 | Transcript : Arctic Bioscience AS, Q4 2023 Earnings Call, Mar 01, 2024 |
Arctic Bioscience AS reported earnings results for the full year ended December 31, 2022. For the full year, the company reported sales was NOK 34.27 million compared to NOK 21.52 million a year ago. Revenue was NOK 34.47 million compared to NOK 21.52 million a year ago.
Net loss was NOK 34.02 million compared to NOK 42.58 million a year ago. Basic loss per share from continuing operations was NOK 1.39 compared to NOK 1.75 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -3.81% | 23.62M | |
| +30.38% | 684B | |
| +26.51% | 568B | |
| -4.36% | 361B | |
| +19.30% | 329B | |
| +3.73% | 284B | |
| +16.70% | 240B | |
| +8.78% | 208B | |
| -7.93% | 200B | |
| +7.68% | 166B |
ARCTIC BIOSCIENCE 